Stockholders' Equity (Details Narrative) - USD ($) |
1 Months Ended | 3 Months Ended | 6 Months Ended | ||||
|---|---|---|---|---|---|---|---|
Feb. 28, 2015 |
Jun. 30, 2008 |
Oct. 31, 2015 |
Jul. 29, 2015 |
Oct. 31, 2014 |
Oct. 31, 2015 |
Oct. 31, 2014 |
|
| Stockholders' Equity | |||||||
| Stock options granted, term | 3 years 1 month | ||||||
| Warrants | |||||||
| Stockholders' Equity | |||||||
| Stock warrants outstanding | 3,358,275 | 3,358,275 | |||||
| Warrants | Minimum | |||||||
| Stockholders' Equity | |||||||
| Exercise price of warrants | $ 2.00 | $ 2.00 | |||||
| Warrants | Maximum | |||||||
| Stockholders' Equity | |||||||
| Exercise price of warrants | $ 13.56 | $ 13.56 | |||||
| Stock-Based Compensation | |||||||
| Stockholders' Equity | |||||||
| Stock options granted | 72,000 | 238,667 | |||||
| Stock based compensation expense | $ 22,000 | $ 5,000 | $ 185,000 | $ 9,000 | |||
| Unrecognized compensation expense | $ 34,000 | $ 34,000 | |||||
| Unrecognized compensation expense, period for recognition | 22 months | ||||||
| Stock Options | |||||||
| Stockholders' Equity | |||||||
| Stock options granted | 8,333 | ||||||
| Stock options granted, fair value at date of grant | $ 15.60 | ||||||
| Stock options granted, term | 10 years | ||||||
| Chief Executive Officer | |||||||
| Stockholders' Equity | |||||||
| Common shares surrendered | 7,265 | ||||||
| Securities Purchase Agreement | Accredited Investors | |||||||
| Stockholders' Equity | |||||||
| Shares of stock sold | 500,000 | ||||||
| Sale of stock, price per share | $ 1.00 | ||||||
| Sale of stock, value | $ 500,000 | ||||||
| Restricted stock issued, shares | 25,000 | 54,667 | |||||
| Restricted stock issued, value | $ 38,000 | $ 88,000 | |||||
| Preferred stock, call features | In September 2015, as a condition of the sale of the approximately 400,000 remaining shares of Series A Stock held by Isaac Capital Group to a group of independent accredited investors, all the residual call options were removed from the Preferred Series A Stock Purchase Agreements. | ||||||
| Private Placement | |||||||
| Stockholders' Equity | |||||||
| Series A preferred stock converted | 102,000 | ||||||
| Common stock issued upon conversion of Series A preferred stock | 510,000 | ||||||
| Reduction of preferred stock upon conversion, value | $ 302,000 | ||||||
| Adjustment to additional paid in capital upon redemption of preferred stock | $ 208,000 | ||||||
| Series A preferred stock and warrants issued | 20,000 | 20,000 | |||||
| Proceeds from issuance of Series A preferred stock and warrants | $ 100,000 | ||||||
| Private placement, description | On November 12, 2014 and February 2, 2015, the Company completed a private placement of an aggregate of 626,600 shares of its Series A Preferred Stock (“Series A Stock”) together with warrants to purchase shares of its common stock (“Preferred Warrant”) at a price of $5.00 per share, in accordance with the Series A Preferred Stock Purchase Agreement dated October 20, 2014 (the “Purchase Agreement”). From the date of respective closings and prior to October 20, 2019 (the “Put/Call Exercise Period”), the investors may exercise a right to purchase and require the Company to sell up to an additional 673,400 shares of Series A Stock. If the investors have not exercised this right during the Put/Call Exercise Period, the Company may exercise a right to cause and require the investors to purchase up to an additional 673,400 shares of Series A Stock, for an aggregate purchase price of $3,367,000. In September 2015, all the residual call options were removed from the Preferred Series A Stock Purchase Agreements. | ||||||
| Private placement, conversion terms | Holders of the Series A Stock shall initially have the right to convert such shares of Series A Stock into the number of authorized but previously unissued shares of the Company’s common stock obtained by dividing the stated value of each share of Series A ($5.00) by $2.00. For each share of Series A Stock, the investors will receive 2.5 Preferred Warrants to purchase the Company’s common stock at an exercise price of $2.50 per share. The Preferred Warrants are exercisable immediately for a period of five years from the date of closing. The exercise price of the Preferred Warrants is subject to adjustments in the case of stock splits, stock dividends, combinations of shares and similar recapitalization transactions. The exercisability of the Preferred Warrants may be limited if upon exercise, the warrant holder or any of its affiliates would beneficially own more than 4.99% of the Company’s Common Stock. | ||||||
| Private placement preferred shares issued | 626,600 | ||||||
| Proceeds from issuance of private placement | $ 2,833,000 | ||||||
| Preferred stock, dividend rate, percentage | 8.00% | ||||||
| Preferred stock, dividend rate, per share dollar amount | $ 0.40 | ||||||
| Preferred stock, dividends recorded | $ 59,000 | $ 122,000 | |||||
| Common stock issued for accumulated dividends | 92,456 | ||||||
| Accumulated dividends, settled through issuance of stock | $ 174,000 | ||||||
| Adjustment to additional paid in capital, settlement of dividends | $ 82,000 | ||||||
| Price per share | $ 5.00 | ||||||